Oral Factor Xa Inhibitors versus Warfarin for the Treatment of Venous Thromboembolism in Advanced Chronic Kidney Disease

INTRODUCTION: Warfarin remains the preferred oral anticoagulant for the treatment of venous thromboembolism (VTE) in patients with advanced chronic kidney disease (CKD). Although the direct oral anticoagulants (DOACs) have become preferred for treatment of VTE in the general population, patients wit...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Adv Hematol
Autores principales: Ahuja, Tania, Sessa, Kelly, Merchan, Cristian, Papadopoulos, John, Green, David
Formato: Artigo
Lenguaje:Inglês
Publicado: Hindawi 2021
Materias:
Research Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7895609/
https://ncbi.nlm.nih.gov/pubmed/33628255
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2021/8870015
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares